rose 241.5% to $7.00 in pre-market trading after the company announced plans to expedite development of fully human anti-Interleukin-6-Receptor monoclonal antibody, a ‘potential treatment of certain …
More 26 Stocks Moving in Wednesday’s Pre-Market Session Videos